BioCentury | Aug 2, 2019
Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

...grants over the next six years, matching Evotec’s in kind contribution. The partners, which include Nosopharm S.A.S....
BioCentury | Nov 13, 2018
Company News

Management tracks: Anchiano, ContraFect

...of R&D and CMO of women’s health company Sojournix Inc. (Arlington, Mass.). Infective disease company Nosopharm S.A.S....
BioCentury | Apr 17, 2018
Distillery Therapeutics

Infectious disease

...Next steps by Nosopharm S.A.S. include IND-enabling studies of NOSO-502, an optimized version of the compound. Nosopharm S.A.S....
...Polikanov, same affiliation as above email: yuryp@uic.edu CONTACT: Maxime Gualtieri, Nosopharm S.A.S., Nimes, France email: m.gualtieri@nosopharm.com Jennie Walters NOSO-502 Nosopharm S.A.S. University...
BioCentury | Apr 9, 2018
Preclinical News

Nosopharm team identifies new class of antibiotics

...Researchers at Nosopharm S.A.S. (Nimes, France) and academic colleagues identified a previously unknown class of naturally produced...
...other antibiotics do, they could help treat bacterial infectious in patients with weakened immune systems. Nosopharm...
...assets are intended to treat or prevent bacterial infection (see BioCentury Innovations, March 29) . Jennie Walters Nosopharm S.A.S. University...
BioCentury | Mar 31, 2017
Financial News

Nosopharm completes venture financing

...Antibiotic company Nosopharm S.A.S. (Nimes, France) raised €2.4 million ($2.6 million) in a venture round from new...
...Partners, Kreaxi and Alto Invest and existing investors on March 28. Nosopharm S.A.S. , Nimes, France Alex Himes Nosopharm S.A.S....
BioCentury | Oct 21, 2013
Company News

Nosopharm infectious news

...Nosopharm S.A.S. , Nimes, France Business: Infectious Antibiotics company Nosopharm received a €870,000 ($1.2 million) grant...
...French government under the Odilorhabdin: Preclinical optimization and study to combat antibiotic resistance (OOPERA) project. Nosopharm's...
...Gram-negative bacteria. The company said the grant will fund preclinical development up to clinical testing. Nosopharm...
Items per page:
1 - 6 of 6
BioCentury | Aug 2, 2019
Company News

Aug. 1 Company Quick Takes: Nektar gains on breakthrough for NKTR-214; plus Adaptive's MRD test, Acadia, Vanda and more

...grants over the next six years, matching Evotec’s in kind contribution. The partners, which include Nosopharm S.A.S....
BioCentury | Nov 13, 2018
Company News

Management tracks: Anchiano, ContraFect

...of R&D and CMO of women’s health company Sojournix Inc. (Arlington, Mass.). Infective disease company Nosopharm S.A.S....
BioCentury | Apr 17, 2018
Distillery Therapeutics

Infectious disease

...Next steps by Nosopharm S.A.S. include IND-enabling studies of NOSO-502, an optimized version of the compound. Nosopharm S.A.S....
...Polikanov, same affiliation as above email: yuryp@uic.edu CONTACT: Maxime Gualtieri, Nosopharm S.A.S., Nimes, France email: m.gualtieri@nosopharm.com Jennie Walters NOSO-502 Nosopharm S.A.S. University...
BioCentury | Apr 9, 2018
Preclinical News

Nosopharm team identifies new class of antibiotics

...Researchers at Nosopharm S.A.S. (Nimes, France) and academic colleagues identified a previously unknown class of naturally produced...
...other antibiotics do, they could help treat bacterial infectious in patients with weakened immune systems. Nosopharm...
...assets are intended to treat or prevent bacterial infection (see BioCentury Innovations, March 29) . Jennie Walters Nosopharm S.A.S. University...
BioCentury | Mar 31, 2017
Financial News

Nosopharm completes venture financing

...Antibiotic company Nosopharm S.A.S. (Nimes, France) raised €2.4 million ($2.6 million) in a venture round from new...
...Partners, Kreaxi and Alto Invest and existing investors on March 28. Nosopharm S.A.S. , Nimes, France Alex Himes Nosopharm S.A.S....
BioCentury | Oct 21, 2013
Company News

Nosopharm infectious news

...Nosopharm S.A.S. , Nimes, France Business: Infectious Antibiotics company Nosopharm received a €870,000 ($1.2 million) grant...
...French government under the Odilorhabdin: Preclinical optimization and study to combat antibiotic resistance (OOPERA) project. Nosopharm's...
...Gram-negative bacteria. The company said the grant will fund preclinical development up to clinical testing. Nosopharm...
Items per page:
1 - 6 of 6